tiprankstipranks
HUTCHMED (China) Limited (HK:0013)
:0013
Want to see HK:0013 full AI Analyst Report?

Compare HUTCHMED (China) (0013) vs. Competitors

7 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
HUTCHMED (China)
HK$21.18
HK$18.44B
4.97
-8.88%
10 Buy
0 Hold
1 Sell
Strong Buy
China Medical System Holdings
HK$14.20
HK$31.20B
19.33
54.10%
3 Buy
0 Hold
0 Sell
Strong Buy
Livzon Pharmaceutical Group
HK$30.94
HK$30.45B
9.36
9.15%
1 Buy
0 Hold
1 Sell
Hold
Shanghai Fosun Pharmaceutical (Group) Co
HK$19.63
HK$70.95B
13.21
36.70%
2 Buy
0 Hold
0 Sell
Moderate Buy
Hansoh Pharmaceutical Group Company Limited
HK$39.76
HK$224.98B
35.71
53.94%
10 Buy
0 Hold
0 Sell
Strong Buy
CanSino Biologics, Inc. Class H
HK$44.94
HK$11.96B
-42.31
-13.46%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:0013
HUTCHMED (China)
21.14
-2.86
-11.92%
HK:0867
China Medical System Holdings
12.79
4.66
57.24%
HK:1513
Livzon Pharmaceutical Group
28.16
3.21
12.86%
HK:2196
Shanghai Fosun Pharmaceutical (Group) Co
19.11
5.61
41.60%
HK:3692
Hansoh Pharmaceutical Group Company Limited
37.10
12.97
53.75%
HK:6185
CanSino Biologics, Inc. Class H
29.38
-4.12
-12.30%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts